Related Experiment Videos
[Circulation effects of noradrenaline in hyperdynamic septic shock]
G Padua1, P Mastroni, G Piredda
1Cattedra di Cardiochirurgia, Università degli Studi di Sassari.
Minerva Anestesiologica
|May 1, 1992
Summary
Norepinephrine (NA) combined with dopamine or dobutamine improved hemodynamics and survival in patients with septic shock and low systemic vascular resistance (SVR). This therapeutic approach demonstrated a higher survival rate in the treated group.
Area of Science:
- Critical Care Medicine
- Pharmacology
- Cardiovascular Physiology
Context:
- Septic shock is a life-threatening condition characterized by circulatory dysfunction.
- Low systemic vascular resistance (SVR) is a common and challenging feature of septic shock.
- Current treatment protocols often involve vasopressors to restore hemodynamic stability.
Purpose:
- To evaluate the efficacy of norepinephrine (NA) in combination with dopamine and/or dobutamine in patients with septic shock and low SVR.
- To assess the impact of this therapeutic protocol on hemodynamic parameters and survival rates.
- To record comprehensive clinical, laboratory, and microbiological data during treatment.
Summary:
- A cohort of 8 patients with septic shock and low SVR received treatment with norepinephrine (NA) in conjunction with dopamine and/or dobutamine.
- The therapeutic protocol resulted in improved hemodynamic condition, including increased SVR and blood pressure.
- Patients treated with NA demonstrated a higher survival rate compared to historical controls or expected outcomes.
Impact:
- The findings suggest that NA, when used with other inotropes/vasopressors, can be an effective strategy for managing septic shock with low SVR.
- This approach may lead to better patient outcomes and increased survival rates in this critical patient population.
- Further research with larger cohorts is warranted to confirm these promising results and optimize treatment protocols.